RCEL
Avita Medical Ltd
NASDAQ: RCEL · HEALTHCARE · MEDICAL DEVICES
$4.32
+2.13% today
Updated 2026-04-30
Market cap
$133.26M
P/E ratio
—
P/S ratio
1.86x
EPS (TTM)
$-1.74
Dividend yield
—
52W range
$3 – $10
Volume
0.2M
WallStSmart proprietary scores
20
out of 100
Grade: F
Strong Sell
Investment rating
5.3
Growth
C+4.5
Quality
C2.0
Profitability
F6.7
Valuation
B2/9
Piotroski F-Score
Weak
-11.9
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →200 stocks currently score above 75
Price targets
Analyst target
$8.59
+98.84%
12-Month target
—
—
Intrinsic (DCF)
$9.98
Margin of safety
+62.73%
0 Strong Buy3 Buy1 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ 62.73% below intrinsic value
+ Debt/equity -0.13x — low leverage
Risks
- Piotroski 2/9 — weak financial health
- Altman Z -11.90 — distress zone
- Thin margins at -67.80%
- Negative free cash flow $-7.15M
- Revenue declining -4.30% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $34.42M | $50.14M | $64.25M | $71.61M | $71.61M |
| Net income | $-26.66M | $-35.38M | $-61.84M | $-48.59M | $-11.62M |
| EPS | — | — | — | — | $-1.74 |
| Free cash flow | $-19.61M | $-39.46M | $-58.27M | $-32.93M | $-7.15M |
| Profit margin | -77.47% | -70.56% | -96.26% | -67.85% | -67.80% |
Peer comparison
Smart narrative
Avita Medical Ltd trades at $4.32. Our Smart Value Score of 20/100 indicates the stock is weak. The company scores 2/9 on the Piotroski F-Score. With an Altman Z-Score of -11.90, it sits in the distress. TTM revenue stands at $71.61M. with profit margins at -67.80%. Our DCF model estimates intrinsic value at $9.98.
Frequently asked questions
What is Avita Medical Ltd's stock price?
Avita Medical Ltd (RCEL) trades at $4.32.
Is Avita Medical Ltd overvalued?
Smart Value Score 20/100 (Grade F, Strong Sell). DCF value $9.98.
What is the price target of Avita Medical Ltd (RCEL)?
The analyst target price is $8.59, representing +98.8% upside from the current price of $4.32.
What is the intrinsic value of Avita Medical Ltd (RCEL)?
Based on our DCF model, intrinsic value is $9.98, a +62.7% margin of safety versus $4.32.
What is Avita Medical Ltd's revenue?
TTM revenue is $71.61M.
Piotroski F-Score?
2/9 — weak financial health.
Altman Z-Score?
-11.90 — distress.
Company info
SectorHEALTHCARE
IndustryMEDICAL DEVICES
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio1.86x
ROE-1,746.00%
Beta1.89
50D MA$4.53
200D MA$4.44
Shares out0.03B
Float0.03B
Short ratio—
Avg volume0.2M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—